Gram-negative and gram-positive antibacterial properties of the whole plant extract of willow herb (epilobium angustifolium)

Biological Research for Nursing

Volumn 14, Issue 1, 2012, Pages 85-89

  Bartfay, Wally J ^a   Bartfay, Emma ^a   Johnson, Julia Green ^a  

^a UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

Author keywords

antibacterial; Epilobium angustifolium; ethnopharmacology; willow herb

Indexed keywords

ANTIINFECTIVE AGENT; PLANT EXTRACT;

ARTICLE; CHEMISTRY; DRUG EFFECT; EPILOBIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; EPILOBIUM; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS;

EID: 84863050472     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800410393947     Document Type: Article

References (26)

1. Amyes S.G.The rise in bacterial resistance is partly because there have been no new classes of antibiotics since the 1960s.British Medical Journal. 2000;320:199-200.
2. Annapurna J.,Chowdary I.,Lalitha G.,Ramakrishna S.,Iyengar D.Antimicrobial activity of Euphorbia nivulia leaf extract.Pharmaceutical Biology. 2004;42:91-93.
3. Battinelli L.,Tita B.,Evandri M.,Mazzanti G.Antimicrobial activity of.Epilobium. Il Farmaco. 2001;56:345-348.
4. Bax R.,Mullan N.,Verhoef J.The millennium bugs. The need for and development of new antibacterials.International Journal of Antimicrobial Agents. 2000;16:51-59.
5. Boucher H.W.,Talbot G.H.,Bradley J.S.,Edwards J.E.,Gilbert D.,Rice L.B.,Bartlett J.Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America.Clinical Infectious Diseases. 2009;48:1-12.
6. Guven K.,Celik S.,Uysal I.Antimicrobial activity of Centaurea species.Pharmaceutical Biology. 2005;43:67-71.
7. Kilic A.,Kilic A.,Inandi T.Folkloric treatment of tinea capitis with.Epilobium angustifolium. Plastic and Reconstructive Surgery. 2001;108:1824-1825.
8. Larson E.Community factors in the development of antibiotic resistance.Annual Review of Public Health. 2007;28:435-437.
9. Maher S.,McClean S.Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.Biochemical Pharmacology. 2006;71:1289-1298.
10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Second edition: Approved standard M7-A2, NCCLS. Villanova, PA: Author; 1990:.
11. Nicasio A.M.,Kuti J.L.,Nicolau D.P.The current state of multidrug-resistant Gram-negative bacilli in North America.Pharmacotherapy. 2008;28:235-249.
12. Norrby S.R.,Nord C.E.,Finch R.Lack of development of new antimicrobial drugs: A potential threat to public health.Lancet Infectious Diseases. 2005;5:115-119.
13. Overbye K.M.,Barrett J.F.Antibiotics: Where did we go wrong?.Drug Discovery Today. 2005;1:45-52.
14. Projan S.J.,Shales D.M.Antibacterial drug discovery: Is it all downhill from here?.Clinical & Microbiology Infections. 2004;10:18-22.
15. Rauha J.,Remes S.,Heinonen M.,Hopia A.,Kahkonen M.,Kujala T.,Vuorela P.Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds.International Journal of Food Microbiology. 2000;56:3-12.
16. ShebitzD. (2003). Plant data sheet. Retrieved March 16, 2006, fromhttp://departments.washington.edu/proppInt/plants/Epilobium.htm.
17. Sheldon A.Antibiotic resistance: A survival strategy.Clinical Laboratory Science. 2005;18:170-181.
18. Steekamp V.,Gouws M.C.,Gulumian M.,Elgorashi E.E.,van Staden J.Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis.Journal of Ethnopharmacology. 2006;103:71-75.
19. Talbot G.H.,Bradley J.,Edwards J.E.,Gilbert D.,Scheld M.,Bartlett J.G.Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Clinical Infectious Diseases. 2006;42:657-668.
20. Tita B.,Abdel-Haq H.,Vitalone A.,Mazzanti G.,Saso L.Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test.Il Farmaco. 2001;56:341-343.
21. Vergidis P.I.,Falagas M.E.Multidrug-resistant Gram-negative bacterial infections: The emerging threat and potential novel treatment options.Current Opinions in Investigative Drugs. 2008;9:176-183.
22. Vitalone A.,McColl J.,Thome D.,Costac L.,Tita B.Characterization of the effect of Epilobium extracts on human cell proliferation.Pharmacology. 2003;69:79-87.
23. Weber C.Update on antimicrobial resistance.Dermatology Nursing. 2006;18:15-19.
24. Wenzel R.The antibiotic pipeline-Challenges, costs and values.New England Journal of Medicine. 2004;351:523-526.
25. Zinner S.H.The search for new antimicrobials: Why we need new options.Expert Review of Antimicrobial & Infectious Therapies. 2005;3:907-913.
26. Zgoda J.R.,Porter J.R.A convenient microdilution method for screening natural products against bacteria and fungi.Pharmaceutical Biology. 2001;39:221-230.